Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
615.97B
Market cap615.97B
Price-Earnings ratio
38.52
Price-Earnings ratio38.52
Dividend yield
2.08%
Dividend yield2.08%
Average volume
8.54M
Average volume8.54M
High today
$257.51
High today$257.51
Low today
$254.00
Low today$254.00
Open price
$255.00
Open price$255.00
Volume
6.37M
Volume6.37M
52 Week high
$281.07
52 Week high$281.07
52 Week low
$184.66
52 Week low$184.66

Stock Snapshot

With a market cap of 615.97B, Johnson & Johnson(JNJ) trades at $255.35. The stock has a price-to-earnings ratio of 38.52 and currently yields dividends of 2.08%.

As of 2026-10-16, Johnson & Johnson(JNJ) stock has fluctuated between $254.00 and $257.51. The current price stands at $255.35, placing the stock +0.5% above today's low and -0.8% off the high.

The Johnson & Johnson(JNJ)'s current trading volume is 6.37M, compared to an average daily volume of 8.54M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $281.07 and a 52-week low of $184.66.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $281.07 and a 52-week low of $184.66.

JNJ News

The Motley Fool 3h
Johnson & Johnson: 3 Key Takeaways for Long-Term Investors

On its third quarter of 2026 earnings call, held on Oct. 13, 2026, Johnson & Johnson (JNJ +0.79%) raised its full-year sales outlook after operational revenue g...

Johnson & Johnson: 3 Key Takeaways for Long-Term Investors
Seeking Alpha 8h
Dividend Roundup: Johnson & Johnson, Coca-Cola, Costco, CVS Health, and more

This week's dividend activity included increased payouts from Interactive Brokers Group (IBKR) and Citizens Financial Group (CFG) as well as declarations from J...

Dividend Roundup: Johnson & Johnson, Coca-Cola, Costco, CVS Health, and more
Simply Wall St 8h
How Investors May Respond To J&J Raised 2026 Guidance

Johnson & Johnson raised its full year 2026 guidance after reporting higher sales from its Innovative Medicine segment, backed by TREMFYA long term Crohn's dise...

How Investors May Respond To J&J Raised 2026 Guidance

Analyst ratings

70%

of 27 ratings
Buy
70.4%
Hold
22.2%
Sell
7.4%

More JNJ News

TipRanks 9h
Johnson & Johnson price target raised to $287 from $275 at Wells Fargo

Wells Fargo analyst Larry Biegelsen raised the firm’s price target on Johnson & Johnson (JNJ) to $287 from $275 and keeps an Overweight rating on the shares. Wi...

New York Times 11h
Chelsea captain Reece James expected to miss around 3 months after knee surgery - The Athletic - The New York Times

...

Chelsea captain Reece James expected to miss around 3 months after knee surgery - The Athletic - The New York Times
24/7 Wall St. 1d
Procter & Gamble Has Raised Its Dividend for 70 Years. These 4 Stocks Also Reward Patience

Investing Procter & Gamble Has Raised Its Dividend for 70 Years. These 4 Stocks Also Reward Patience A dividend that keeps growing beats a fat yield that gets c...

Procter & Gamble Has Raised Its Dividend for 70 Years. These 4 Stocks Also Reward Patience
TipRanks 1d
Johnson & Johnson price target lowered to $292 from $294 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on Johnson & Johnson to $292 from $294 and keeps an Overweight rating on the shares. The company posted “a genera...

Benzinga 2d
Johnson & Johnson Q3 Sets 'Negative Tone For Broader Pharma Sector': Analysts

Shares of Johnson & Johnson (NYSE:JNJ) rose in early trading on Wednesday, after the company reported upbeat third-quarter results. Here are some key analyst t...

Johnson & Johnson Q3 Sets 'Negative Tone For Broader Pharma Sector': Analysts
Benzinga 2d
These Analysts Cut Their Forecasts On Johnson & Johnson After Q3 Results

Johnson & Johnson (NYSE:JNJ) on Tuesday reported upbeat third-quarter results and raised its full-year guidance. Adjusted earnings fell 7.5% year over year to...

These Analysts Cut Their Forecasts On Johnson & Johnson After Q3 Results
24/7 Wall St. 2d
The 3-Bucket Income System Making $13,000/Month in Pure Dividends

Personal Finance The 3-Bucket Income System Making $13,000/Month in Pure Dividends Most investors chase the highest yield they can find, but that single decisio...

The 3-Bucket Income System Making $13,000/Month in Pure Dividends

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.